CVS Health Corporation reports fourth quarter and full-year 2024 results – CVS Health
Our purpose is simple and clear: Bringing our heart to every moment of your health.Our approach ties directly to our purpose: Bringing our heart to every moment of your health™.Find everyday health news, media resources and more.Find out how we’re touching people, communities, businesses and the planet.
February 12, 2025
|3 minute read time
View print-friendly version (PDF)“Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits segment. Through the continued dedication of our colleagues, we will be positioned for strong performance in 2025 as we deliver simply better care for consumers while improving outcomes and reducing costs.”— David Joyner, CVS Health President and CEO WOONSOCKET, RHODE ISLAND, February 12, 2025 — CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2024.Fourth quarter GAAP diluted EPS of $1.30 decreased from $1.58 in the prior year and Adjusted EPS of $1.19 decreased from $2.12 in the prior year, primarily due to a decline in the Health Care Benefits segment’s operating results, which reflect continued utilization pressure and the unfavorable impact of the Company’s Medicare Advantage star ratings for the 2024 payment year.The information presented above includes both GAAP and non-GAAP financial measures to assist in the comparison of the Company’s past financial performance with its current financial performance. See “Non-GAAP Financial Information” in the full press release, which is linked below, for explanations of the non-GAAP financial measures presented above and reconciliations of each non-GAAP financial measure to the most directly comparable GAAP financial measure.Please review the entire press release for the quarterly period, which provides important additional information related to our financial results. The full press release can be downloaded here (PDF).Visit Investor Relations for more about Q4 2024 earnings.(1) The Company defines adjusted operating income as operating income (GAAP measure) excluding the impact of amortization of intangible assets, net realized capital gains or losses and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance, such as acquisition-related transaction and integration costs, restructuring charges, office real estate optimization charges, opioid litigation charges and losses on assets held for sale. The Chief Operating Decision Maker (“CODM”) uses adjusted operating income as its principal measure of segment performance as it enhances the CODM’s ability to compare past financial performance with current performance and analyze underlying business performance and trends. The consolidated measure is not determined in accordance with GAAP and should not be considered a substitute for, or superior to, the most directly comparable GAAP measure, consolidated operating income. See “Non-GAAP Financial Information” in the full press release linked above for additional information regarding the items excluded from consolidated operating income in determining consolidated adjusted operating income.(2) GAAP diluted earnings per share and Adjusted EPS, respectively, are calculated by dividing net income attributable to CVS Health and adjusted income attributable to CVS Health by the Company’s weighted average diluted shares outstanding. The Company defines adjusted income attributable to CVS Health as net income attributable to CVS Health (GAAP measure) excluding the impact of amortization of intangible assets, net realized capital gains or losses and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance, such as acquisition-related transaction and integration costs, restructuring charges, office real estate optimization charges, opioid litigation charges, losses on assets held for sale, gains on early extinguishment of debt, as well as the corresponding income tax benefit or expense related to the items excluded from adjusted income attributable to CVS Health. See “Non-GAAP Financial Information” in the full press release linked above for additional information regarding the items excluded from net income attributable to CVS Health in determining adjusted income attributable to CVS Health.Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.comEthan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com
Please select at least one of the above.
Please enter a valid email.
Please enter a valid email© Copyright 1999 – 2025 CVS HealthTerms of usePhoto and video available via the CVS Health Newsroom are for use only by accredited members of the media. We will permit use of photography and video available via the CVS Health Newsroom by the media as long as the use will not disparage CVS Health nor imply endorsement by CVS Health Newsroom, and the photography cannot be changed or manipulated in any way with the exception of resizing or cropping. Please read the terms of use, indicate you read the statement by checking the checkbox, and then click the Download button.
Invalid Input
